Kojic Acid: What It Does, What It Doesn't, and Why It's Unstable

Kojic acid has been quietly popular in skincare for years, mostly in the pigmentation corner of the market — brightening serums, soaps, creams, all promising to fade dark marks and even out skin tone. It’s not new, and it’s not a social-media discovery: the ingredient has been used in East Asian cosmetics since the 1980s. What’s newer is the volume of products arriving on the UK market, often with bold claims and not much context about the ingredient’s real strengths and genuine drawbacks. Because it does have both.

What it actually is

Kojic acid is a natural by-product of fungal fermentation — specifically, it’s produced by several species of Aspergillus and Penicillium fungi during the fermentation of rice, soy and other starches. If you’ve ever heard it connected to sake brewing, that’s accurate: it was first isolated from the fungal cultures used in Japanese rice wine production. The compound itself is a small, water-soluble organic molecule, which matters for formulation and for how it interacts with skin.

Its mechanism is straightforward: kojic acid inhibits tyrosinase, the enzyme responsible for catalysing the conversion of tyrosine to melanin. Specifically, it chelates the copper ions at the enzyme’s active site — tyrosinase needs copper to function, and without it, melanin production slows down. This makes kojic acid a direct competitor to other tyrosinase inhibitors like alpha arbutin, hydroquinone and vitamin C, though they each block the enzyme through different sub-mechanisms.

What the evidence actually supports

Kojic acid has a reasonable evidence base — better than many trending ingredients, thinner than the heavy hitters like retinoids or L-ascorbic acid. Here’s where the research is strongest, and where it trails off.

Tyrosinase inhibition is well-established in vitro. Cell-culture and enzyme-assay studies consistently show that kojic acid reduces melanin production, and the copper-chelation mechanism is well characterised. This is the most solid piece of the evidence.

Clinical improvement in pigmentation has been demonstrated in several trials, though most are small. Studies comparing kojic acid to hydroquinone — typically at 2% kojic acid against 2–4% hydroquinone — generally show comparable results over eight to twelve weeks for mild to moderate hyperpigmentation, though hydroquinone tends to produce slightly faster and more pronounced effects. A few studies have found kojic acid slightly less effective, a few roughly equivalent. None put it ahead.

Combination formulations are where most of the positive clinical data comes from. Kojic acid paired with glycolic acid, or with hydroquinone and a corticosteroid (the classic Kligman’s formula variant), tends to outperform kojic acid alone. That’s worth knowing when you see impressive results attributed to a “kojic acid” product — the supporting ingredients are often doing meaningful work.

What’s less well supported: claims about anti-ageing beyond pigmentation, antibacterial benefits (some exist but are marginal), and any suggestion that kojic acid can address deep or hormonally driven melasma on its own. For stubborn pigmentation, tranexamic acid has a stronger emerging case, particularly when the oral route is an option under medical supervision.

The stability problem — and it’s a real one

This is where kojic acid differs from most of its competitors, and not in its favour. Kojic acid is notoriously unstable in formulation. It oxidises readily on exposure to air and light, turning brown and losing efficacy. Products that start pale can darken within weeks of opening, and once they’ve oxidised, the active ingredient is degraded — you’re applying something that isn’t doing what it did when the bottle was sealed.

Formulators have known about this for decades, and it’s the primary reason a derivative called kojic acid dipalmitate exists. It’s a lipid-soluble ester that’s considerably more stable — it won’t darken in the bottle or break down as easily. The trade-off is that it’s also less potent: the esterification that makes it stable also slows the release of active kojic acid at the skin’s surface. Kojic acid dipalmitate is a reasonable ingredient, but it’s not the same thing as kojic acid, despite often being marketed interchangeably. If the label says “kojic acid dipalmitate” rather than “kojic acid,” you’re getting the more stable but weaker version.

If you’re using a product with pure kojic acid, keep it in a cool, dark place, use it up relatively quickly after opening, and take any colour change as a sign it’s past its useful life.

Irritation and safety

Kojic acid is more irritating than several of its pigmentation-fighting peers. Contact dermatitis — redness, itching, sometimes a stinging or burning sensation — is a well-documented side effect, particularly at higher concentrations (above 2%) and with prolonged use. This isn’t universal, and many people use it without issues, but the irritation rate is higher than you’d find with alpha arbutin or niacinamide, which are genuinely gentle for most skin types.

There’s also a photosensitivity consideration. By inhibiting melanin production, kojic acid reduces the skin’s own modest UV defence, which makes sun protection even more important than usual when using it — and it should already be non-negotiable for anyone working on pigmentation, since UV exposure is the main driver of the problem in the first place.

The EU’s Scientific Committee on Consumer Safety has evaluated kojic acid multiple times and currently permits its use in cosmetics at concentrations up to 1% in leave-on products, reflecting a balance between efficacy and safety. Some products sold online exceed this, particularly soaps and products imported from outside the EU/UK regulatory framework. Higher isn’t automatically better here — it’s higher risk of irritation for uncertain additional benefit.

How it compares to other brightening ingredients

If you’re choosing between pigmentation ingredients, it helps to know where each sits:

Hydroquinone remains the most effective single topical agent for pigmentation. Kojic acid is sometimes called its natural alternative, but the potency gap is real. Hydroquinone is prescription-only in the UK and carries long-term-use concerns (ochronosis, rebound pigmentation), which is part of why alternatives exist — not because the alternatives are better, but because hydroquinone’s downsides limit who can or should use it.

Alpha arbutin is gentler than kojic acid, with less irritation potential, but also milder in effect. If you have sensitive or reactive skin, arbutin is the safer starting point. If arbutin hasn’t produced enough change after three months, kojic acid is a reasonable next step.

Vitamin C (L-ascorbic acid specifically) inhibits tyrosinase via a different mechanism and brings antioxidant benefits that kojic acid doesn’t offer. The two can be used together, attacking pigmentation from two angles. Vitamin C’s instability problems are different from kojic acid’s but equally real — see our comparison of vitamin C forms.

Tranexamic acid works through a genuinely different pathway (plasminogen inhibition rather than tyrosinase inhibition), making it complementary rather than competing. For melasma in particular, tranexamic acid has a stronger evidence base than kojic acid.

Azelaic acid at 15–20% offers both tyrosinase inhibition and anti-inflammatory effects, with a better-tolerated side-effect profile than kojic acid and a solid evidence base for both pigmentation and acne. It’s arguably the more versatile choice if you’re dealing with more than one concern.

The soap question

Kojic acid soap is genuinely popular — it consistently outsells kojic acid serums in search interest — and it’s worth addressing specifically. The theory is that the soap delivers kojic acid to the skin during cleansing, offering a gradual brightening effect with regular use.

The problem is contact time. A wash-off product sits on the skin for seconds to minutes, not the hours that a leave-on serum provides. The evidence for wash-off kojic acid products is thinner than for leave-on formulations, and the mechanism — brief exposure to a somewhat unstable, concentration-limited active — makes it genuinely unclear how much effect the ingredient is having versus the placebo of routine. Some people report results, and it’s cheap enough that trying isn’t a significant investment, but if you’re serious about pigmentation outcomes, a leave-on product with a stated concentration is the more evidence-consistent approach.

Who gets the most from it

Post-inflammatory hyperpigmentation — the marks left behind by breakouts, irritation or injury — is the most responsive category. These marks are typically epidermal (surface-level) and actively fading already; kojic acid can accelerate the process.

Mild to moderate sun damage — age spots, uneven tone from cumulative UV exposure — also responds reasonably well, particularly when combined with consistent sun protection.

Darker skin tones should approach with some caution. Kojic acid’s higher irritation potential is relevant here because irritation itself can trigger more pigmentation in melanin-rich skin — exactly the opposite of the goal. Starting at a lower concentration and monitoring for any inflammatory response is sensible.

Where it’s less likely to deliver: deep melasma, hormonal pigmentation, significant structural sun damage. These need either stronger interventions, professional treatments, or a combination approach — kojic acid alone isn’t going to produce dramatic results for these concerns.

Using it in practice

Most leave-on products sit at 1–2% kojic acid, which aligns with both the regulatory framework and the bulk of the evidence. Apply after cleansing and any water-based steps, before heavier creams and oils — the same position in a layering sequence as most actives.

It pairs reasonably with:

• Vitamin C — complementary tyrosinase-inhibition mechanisms
• Niacinamide — blocks melanosome transfer, a different pigmentation pathway
• AHAs — exfoliation lifts pigmented surface cells and may improve penetration, but watch for compounding irritation; don’t stack kojic acid and glycolic acid on the same evening if your skin is reactive

Avoid pairing with other known irritants on the same application — benzoyl peroxide, high-strength retinoids — unless your skin has a demonstrated tolerance. Introducing kojic acid on alternate evenings first, rather than daily, is a reasonable precaution.

Sunscreen is non-negotiable. UV exposure directly undermines every pigmentation treatment, and kojic acid’s reduction of melanin production makes skin slightly more vulnerable to UV damage than it otherwise would be.

Give it eight to twelve weeks. If you haven’t seen any change by three months, it’s not the right ingredient for your particular concern.

Common questions

Is kojic acid safe? At concentrations up to 1% in leave-on products and 2% in wash-off products, yes — this is within the EU/UK regulatory limit. Higher concentrations carry more irritation risk without clearly better results.

Can I use kojic acid with retinol? In principle, yes, but both are potential irritants. If you want to use both, try them on alternate evenings initially rather than layering them on the same night, and stop if irritation develops.

Does kojic acid lighten skin permanently? No. Kojic acid inhibits new melanin production; it doesn’t destroy melanocytes or permanently alter pigmentation. Once you stop using it, melanin production returns to its baseline. This is a maintenance ingredient, not a one-off treatment.

Why has my kojic acid product turned brown? Oxidation. The active ingredient has degraded and is likely less effective. Replace it — there’s no recovering oxidised kojic acid.

Is kojic acid better than alpha arbutin? Stronger in some respects (more potent tyrosinase inhibition) but also more irritating and less stable. Alpha arbutin is the gentler, lower-risk option; kojic acid is the step up if gentler options haven’t delivered enough change.

The bottom line

Kojic acid is a legitimate, well-characterised pigmentation ingredient with a clear mechanism and a decent — if not overwhelming — body of evidence. It can soften the appearance of dark marks, sun spots and uneven tone, particularly as part of a combination approach with sun protection and complementary actives.

Its real downsides are instability (products degrade visibly and lose efficacy) and a higher irritation rate than gentler alternatives like alpha arbutin or niacinamide. It’s not a gentle ingredient, not a miracle one, and not a substitute for hydroquinone when hydroquinone-level results are genuinely needed. The soap format is popular but thinly evidenced; leave-on products at 1–2% are the more evidence-supported choice.

Use it if milder pigmentation ingredients haven’t produced enough change and your skin can tolerate it. Skip it if your skin is reactive, if arbutin or vitamin C are already delivering acceptable results, or if you’re dealing with deep pigmentation that needs professional-level intervention. A modest ingredient with genuine utility and genuine limitations — which is more useful to know than a marketing pitch in either direction.

This article is for informational purposes only and does not constitute medical advice. If you have concerns about skin pigmentation, particularly sudden or rapidly changing pigmentation, consult a dermatologist or your GP.